Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;21(3):243-249.
doi: 10.2174/1871525721666230126114224.

6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors

Affiliations

6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors

Rami A Al-Horani. Cardiovasc Hematol Agents Med Chem. 2023.

Abstract

Keywords: Isoquinolines; anticoagulants; clotting; enzyme inhibitors; factor XIIa.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The author declares no conflict of interest, financial or otherwise.

Figures

Fig. (1).
Fig. (1).
Key derivatives of 6-(Arylaminomethyl) Isoquinolines are claimed as FXIIa inhibitors in this patent.

Similar articles

Cited by

References

    1. Ivanov I; Matafonov A; Sun M; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D Proteolytic properties of single-chain factor XII: A mechanism for triggering contact activation. Blood, 2017, 129(11), 1527–1537. 10.1182/blood-2016-10-744110 - DOI - PMC - PubMed
    1. Pathak M; Manna R; Li C; Kaira BG; Hamad BK; Belviso BD; Bonturi CR; Dreveny I; Fischer PM; Dekker LV; Oliva MLV; Emsley J Crystal structures of the recombinant β-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics. Acta Crystallogr. D Struct. Biol, 2019, 75(6), 578–591. 10.1107/S2059798319006910 - DOI - PubMed
    1. Dementiev A; Silva A; Yee C; Li Z; Flavin MT; Sham H; Partridge JR Structures of human plasma β–factor XIIa cocrystallized with potent inhibitors. Blood Adv., 2018, 2(5), 549–558. 10.1182/bloodadvances.2018016337 - DOI - PMC - PubMed
    1. Fischer PM Design of small-molecule active-site inhibitors of the S1A family proteases as procoagulant and anticoagulant drugs. J. Med. Chem, 2018, 61(9), 3799–3822. 10.1021/acs.jmedchem.7b00772 - DOI - PubMed
    1. Hamad BK; Pathak M; Manna R; Fischer PM; Emsley J; Dekker LV Assessment of the protein interaction between coagulation factor XII and corn trypsin inhibitor by molecular docking and biochemical validation. J. Thromb. Haemost, 2017, 15(9), 1818–1828. 10.1111/jth.13773 - DOI - PMC - PubMed